SCHEMBL9523248

SCHEMBL9523248

O=CC12CCN(CC1)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3950910 0.91
SCHEMBL2421100 0.82
SCHEMBL8457309 0.69
SCHEMBL9049519 0.61 CHRM2 (0.32)
SCHEMBL9376959 0.60 CHRM2 (0.34)
SCHEMBL14699885 0.55
SCHEMBL5263192 0.53
SCHEMBL20220999 0.53
SCHEMBL11722589 0.53
SCHEMBL2362307 0.53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0338723-B1 NOVEL COMPOUNDS BEECHAM GROUP PLC (GB) 1993-08-04 EP claimed
US-5110828-A Treatment or prophylaxis of dementia BEECHAM GROUP P.L.C. (GB) 1992-05-05 US claimed
EP-0338723-A1 Novel compounds BEECHAM GROUP PLC (GB) 1989-10-25 EP claimed
EP-0338723-B1 NOVEL COMPOUNDS BEECHAM GROUP PLC (GB) 1993-08-04 EP disclosed
US-5110828-A Treatment or prophylaxis of dementia BEECHAM GROUP P.L.C. (GB) 1992-05-05 US disclosed
US-5091397-A Cognition activators BEECHAM GROUP P.L.C. (GB) 1992-02-25 US disclosed
EP-0363085-A2 Novel compounds BEECHAM GROUP PLC (GB) 1990-04-11 EP disclosed
EP-0338723-A1 Novel compounds BEECHAM GROUP PLC (GB) 1989-10-25 EP disclosed